The DEtermining Statin Intolerance FOr Rosuvastatin (DESIFOR) Trial
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This study will enroll patients who previously were not able to tolerate being on a statin
medication due to muscle-related side effects. Research has shown that many people who have
muscle symptoms on statin therapy do not experience the same side effects if they try it
again later. This study is part of a larger effort to:
- See how common it is for patients to still be intolerant of statin medication after
trying it a second time; and
- For those patients who do tolerate being on a statin after trying it a second time, see
how common it is for them to still be taking the statin 3 months after completing the
main part of the study.
Patients who agree to participate will be given a 5 month randomly allocated supply of statin
and placebo and track their symptoms weekly.